<DOC>
	<DOCNO>NCT00345319</DOCNO>
	<brief_summary>Evaluate immunogenicity safety rabies vaccine give post-exposure prophylaxis regimen healthy child adult age 10-60 year .</brief_summary>
	<brief_title>Purified Rabies Vaccine Human Use ( Chick-embryo Cell )</brief_title>
	<detailed_description />
	<mesh_term>Rabies</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>male female healthy subject age 1060 year old history rabies immunization previous exposure suspect rabid animal within last 12 month significant acute chronic infection require systemic antibiotic treatment antiviral therapy within past 7 day treatment corticosteroid , immunosuppressive antimalaria drug two month period enrollment known/suspected immunodeficiency , autoimmune disease , immunologic disorder know hypersensitivity neomycin , tetracycline , amphotericinB , vaccine component</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>rabies</keyword>
	<keyword>vaccine</keyword>
	<keyword>post-exposure prophylaxis</keyword>
</DOC>